⌘K
Change language Switch ThemeSign In
Narrow Mode
Nuanced Perspectives on mRNA Cancer Cures and Regulatory Hurdles ================================================================
Nuanced Perspectives on mRNA Cancer Cures and Regulatory Hurdles ================================================================  ### Patrick Collison
@patrickc
• According to the story, the dog's cancer has not been cured.
• Absent all regulatory and manufacturing constraints, we could not just synthesize magic mRNA cancer cures. The technology is very promising, but it's not yet any kind of panacea.
• The emergent system of regulators and manufacturers is indeed far too conservative, and small-scale experimentation is much harder than it should be. More people should read the first part of The Rise and Fall of Modern Medicine. Recommend @RuxandraTeslo, @PatrickHeizer for more.
Mar 15, 2026, 4:57 PM View on X
82 Replies
149 Retweets
1,979 Likes
198.9K Views P Patrick Collison @patrickc
One Sentence Summary
Patrick Collison discusses the current limitations of mRNA cancer treatments and critiques the overly conservative nature of medical regulatory systems.
Summary
In this tweet, Patrick Collison provides a grounded perspective on biotechnology, clarifying that while mRNA technology is promising, it is not yet a 'panacea' or a magic cure for cancer. He highlights a systemic issue where the current landscape of regulators and manufacturers is excessively conservative, making small-scale experimentation much harder than necessary. He concludes by recommending 'The Rise and Fall of Modern Medicine' and experts like Ruxandra Teslo to further explore these challenges.
AI Score
84
Influence Score 395
Published At Today
Language
English
Tags
mRNA
Biotech
Regulation
Medical Innovation
Progress Studies HomeArticlesPodcastsVideosTweets
Nuanced Perspectives on mRNA Cancer Cures and Regulatory ... ===============